Consistent with clinical trial outcomes in NASH patients, both lanifibranor and semaglutide improved NASH while only lanifibranor reduced fibrosis in GAN DIO-NASH-HCC mice
4,5 A rise in HbA1c values after stopping GLP-1s has also been found in prior research, with a 0.65 percentage point increase, 6 though long-term glycemic trajectories after discontinuation remain less understood
Understanding these contraindications is essential for healthcare providers and patients to ensure safe and appropriate use of this compounded medication
How semaglutide works Mimics gut hormones Semaglutide mimics the hormone GLP-1
Lawitz EJ, Fraessdorf M, Neff GW, Schattenberg JM, Noureddin M, Alkhouri N, Schmid B, Andrews CP, Takcs I, Hussain SA, Fenske WK, Gane EJ, Hosseini-Tabatabaei A, Sanyal AJ, Mazo DF, Younes R
Dispose of your needle Please do not reuse needles for injecting the medication